Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China · Delayed Price · Currency is CNY 47.09
-0.09 (-0.19%)
Oct 28, 2026, 4:00 PM EDT
SHE:301108 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 759.32 | 649.22 | 403.81 | 665.16 | 1,005 | 1,416 |
Short-Term Investments | - | 240 | 429.05 | 264.03 | - | - |
Trading Asset Securities | 246.51 | 248.81 | 659.33 | 410.49 | 300.62 | - |
Cash & Short-Term Investments | 1,006 | 1,138 | 1,492 | 1,340 | 1,305 | 1,416 |
Cash Growth | -8.76% | -23.73% | 11.38% | 2.64% | -7.80% | 340.50% |
Accounts Receivable | 221.9 | 236.44 | 135.76 | 170.88 | 139.01 | 161.97 |
Other Receivables | 83.11 | 69.26 | 8.53 | 3.44 | 1.9 | 9.7 |
Receivables | 305.01 | 305.7 | 144.28 | 174.32 | 140.91 | 171.67 |
Inventory | 108.35 | 90.64 | 77.19 | 68.93 | 64.18 | 142.63 |
Other Current Assets | 208.92 | 13.56 | 8.06 | 4.63 | 5.16 | 12.8 |
Total Current Assets | 1,628 | 1,548 | 1,722 | 1,588 | 1,515 | 1,743 |
Property, Plant & Equipment | 560.93 | 582.54 | 299.43 | 263.7 | 235.98 | 276.34 |
Long-Term Investments | 222.87 | 107.74 | 14.43 | 244.09 | 280.52 | - |
Other Intangible Assets | 69.84 | 62.92 | 34.45 | 35.28 | 28.65 | 29.42 |
Long-Term Deferred Tax Assets | 10.4 | 3.35 | - | - | - | 3.78 |
Long-Term Deferred Charges | 28.52 | 23.03 | 2.79 | 1.87 | - | - |
Other Long-Term Assets | 56.78 | 0.8 | 7.82 | 16.3 | 6.28 | 0.33 |
Total Assets | 2,577 | 2,328 | 2,081 | 2,149 | 2,067 | 2,053 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 372.41 | 281.36 | 187.82 | 210.43 | 179.56 | 251.72 |
Accrued Expenses | 10.16 | 15.63 | 9.69 | 12.99 | 9.89 | 11.35 |
Short-Term Debt | 106.1 | 5.64 | - | - | - | - |
Current Portion of Leases | - | 4.35 | 7.49 | 8.26 | 13.39 | 5.36 |
Current Income Taxes Payable | 14.28 | 13.64 | 1.23 | 5.95 | 2.8 | 7.27 |
Current Unearned Revenue | 0.76 | 1.05 | 3.7 | 1.45 | 28.39 | 11.22 |
Other Current Liabilities | 85.91 | 61.86 | 2.77 | 2.84 | 2.16 | 4.48 |
Total Current Liabilities | 593.28 | 383.53 | 212.7 | 241.92 | 236.18 | 291.39 |
Long-Term Debt | - | - | - | - | 5.74 | 5.49 |
Long-Term Leases | 24.29 | 27.65 | 1.18 | 9.65 | 12.77 | 29.11 |
Long-Term Unearned Revenue | 38.22 | 16.45 | 15.97 | 19.51 | 18.3 | 14.8 |
Long-Term Deferred Tax Liabilities | 10.26 | 16.63 | 21.52 | 17.74 | 14.74 | 18.3 |
Other Long-Term Liabilities | 2.13 | 2.19 | 2.23 | 1 | - | - |
Total Liabilities | 668.18 | 446.44 | 253.6 | 289.82 | 287.73 | 359.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 112.56 | 112.56 | 81.21 | 81.21 | 81.21 | 81.21 |
Additional Paid-In Capital | 980.11 | 967.52 | 1,022 | 1,024 | 1,019 | 1,013 |
Retained Earnings | 816.64 | 801.85 | 743.87 | 753.57 | 678.98 | 598.92 |
Treasury Stock | - | - | -20.06 | - | - | - |
Comprehensive Income & Other | -0.02 | -0.05 | - | - | - | - |
Total Common Equity | 1,909 | 1,882 | 1,827 | 1,859 | 1,779 | 1,693 |
Minority Interest | - | - | 0.01 | 0.3 | - | - |
Shareholders' Equity | 1,909 | 1,882 | 1,827 | 1,859 | 1,779 | 1,693 |
Total Liabilities & Equity | 2,577 | 2,328 | 2,081 | 2,149 | 2,067 | 2,053 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 134.05 | 37.64 | 8.67 | 17.91 | 31.89 | 39.96 |
Net Cash (Debt) | 871.78 | 1,100 | 1,484 | 1,322 | 1,273 | 1,376 |
Net Cash Growth | -18.39% | -25.82% | 12.24% | 3.81% | -7.44% | 407.47% |
Net Cash Per Share | 7.68 | 9.68 | 12.96 | 11.64 | 11.23 | 15.72 |
Filing Date Shares Outstanding | 113.65 | 112.56 | 112.56 | 113.6 | 113.69 | 113.69 |
Total Common Shares Outstanding | 113.65 | 112.56 | 112.56 | 113.69 | 113.69 | 113.69 |
Working Capital | 1,035 | 1,164 | 1,509 | 1,346 | 1,279 | 1,451 |
Book Value Per Share | 16.80 | 16.72 | 16.23 | 16.35 | 15.65 | 14.89 |
Tangible Book Value | 1,839 | 1,819 | 1,793 | 1,823 | 1,750 | 1,664 |
Tangible Book Value Per Share | 16.19 | 16.16 | 15.93 | 16.04 | 15.40 | 14.64 |
Buildings | - | 280.51 | 147.96 | 105.94 | 64.63 | 64.63 |
Machinery | - | 381.62 | 339.78 | 303.02 | 285.71 | 293.38 |
Construction In Progress | - | 125.48 | 5.36 | 4.1 | 4.43 | 6.86 |